From Recent Issues

Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?

Abstract: Ulcerative colitis and Crohn’s disease are chronic, progressive inflammatory bowel diseases (IBDs) and are without a known cure. Janus kinase (JAK) is a family of […]

The Importance of Making an Accurate Diagnosis for Hepatic Encephalopathy

Patient Case A 43-year-old White male with metabolic syndrome presented with complaints of fatigue and feeling distracted. Blood work showed a mild increase in aspartate aminotransferase […]

Recent Approaches in Portal Hypertension Involving Risk Stratification and Medical Management 

Abstract: Portal hypertension leads to the formation of portosystemic collaterals that divert portal blood to the systemic circulation and bypass the liver, resulting in multiple severe […]


Highlights in Ulcerative Colitis From the American College of Gastroenterology Annual Scientific Meeting

A Review of Selected Presentations From ACG 2022 October 21-26, 2022  •  Charlotte, North Carolina Duration of Response to Ozanimod After Treatment Withdrawal: Results From the […]

Highlights in Ulcerative Colitis From Digestive Disease Week 2022

A Review of Selected Presentations From DDW 2022 • May 21-24, 2022 • San Diego, California   Recapture of Response With Ozanimod in Patients With Moderately […]

Highlights in Ulcerative Colitis From the 17th Congress of the European Crohn’s and Colitis Organisation

Rapidity of Ozanimod-Induced Symptomatic Response and Remission in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Induction Period of True North Ozanimod is […]

Millennium Medical Publishing, Inc